REALATED ARTICLES

Click on a word or phrase in our Tag Cloud and see all related articles listed below.

Current tag:

Unilever enters collaboration with BioLeap

January 6, 2011. Unilever today announced that it has entered into a partnership with New Jersey-based BioLeap to apply their molecular-design technology to the development of innovative consumer products. Terms of the transaction are not being disclosed.

The two-year initiative will bring together a worldwide team of Unilever and BioLeap scientists working on the core biology of ageing. The programme is targeting a range of benefit areas of interest to Unilever. Unilever’s Chief R&D Officer, Genevieve Berger said, “Our R&D activities form the link between science and consumer needs, all the more so as consumers become increasingly health-conscious. This collaboration with BioLeap is another example of the commitment at Unilever to partner innovators from outside the business with specific biotech assets and knowledge with our own in-house science and development experts based in our six core laboratories across the world. “I see the key benefits of this collaboration with BioLeap being the development of superior products across a number of categories and exclusivity that will potentially give us competitive advantage in the marketplace.” As consumer demand for healthy living and ageing products increases, Unilever is strategically positioning itself to meet this need through combining its own considerable R&D resource with complimentary technical assets. BioLeap’s molecular-design technology will enable Unilever to build differentiated, health enhancing products spanning several categories. Work on the project will begin immediately.

Disclaimer: You agree that B2Bioworld is not responsible and will not be held liable for any third party content on its sites or any third-party content, products or services available on other web sites accessed through links from B2Bioworld sites. Links to third-party sites are for your convenience only, and their inclusion on B2Bioworld's sites does not imply any endorsement, guarantee, warranty or representation by B2Bioworld.

Turkish Chemicals Industry: Opportunities and Threats

Timur Erk, President of TKSD on re-building Turkey’s chemicals industry

tl_files/images/images_we_own/b2bio content/photo library/editorial content/B2Bio100622_TimurErk5_wk011b_200x202.gif September 2010. What makes Turkey’s chemicals industry more competitive beyond drivelling speeches? How should current petrochemical projects be assessed at Izmir, Adana-Ceyhan and in other parts of the country? Then, what are roles for biosimilars? How could domestic research in nanotechnology and biotechnology contribute to modernisation of the industry sector.

Timur Erk, President of TKSD, the Turkish Chemical Industry Association offers an unvarnished look at weaknesses of the draught horse for the country’s economy. In the exclusive interview with B2Bioworld he is discussing sensitive issues of state aids, unregistered trading, and hazardous waste treatment.

There are real threats, but also opportunities for those who learn their lesson.

Resolving the Innovation Paradox

Dr. Günter von Au, Designated Board Member Clariant AG and CEO Süd-Chemie AG

UK Chemical Industries’ Lessons From the Recession

Dr John Saul, past President of the British Chemical Industries Association on Issues For a Sustainable Future of the Sector

Turkey’s Chemicals Industry in Search of Modernisation

Fighting Crisis in the Chemicals Industry!

Dott. Giorgio Squinzi, CEO MAPEI SpA and past President FEDERCHIMICA

What Future for the Chemicals Industry?

Dr. Stefan Marcinowski, Member of the Board BASF SE

Swiss Biotech and Chemicals Industry Team Up for Industrial Biotech

REACH in Practice - Biofuels and Lubricity Agents

Richard Taylor, Global Manager OGC Tech Support & REACH, SGS SA

If you would like to read more, please proceed to the download section.

Important: After pressing "Buy this article (PayPal)" below you will be taken to the PaypPal checkout page. There you must press the orange "Return To BioBusinessMedia" button in order to download your article.
In buying this article you agree with our Terms & Conditions which you can consult here.